Exosome Blood-Based Biomarker Discovery

September 20, 2013 Leave a comment

Eli Lilly Enters Collaboration Agreement with Exosome Diagnostics NEW YORK September 19, 2013 — Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker discovery and validation using Exosome Diagnostics ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Blood-Based Biomarker

Exosome Blood-Based Biomarker Discovery

Extracellular vesicles from the placenta may offer major clues on the in utero development of neurobehavioral disorders

Exai Bio’s RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy, Overcoming Many Limitations of DNA-based Approaches

HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment

NVIGEN unveils groundbreaking comprehensive liquid biopsy – multimodal biomarker detection enabled by highly versatile nanoparticle capture

SEVtras delineates small extracellular vesicles at droplet resolution from single-cell transcriptomes

Extracellular vesicles: biological packages that modulate tumor cell invasion